Essentials
INFORMATION FROM INDUSTRY
ARTICLES
Within a week of Sandoz applying for approval of it's biosimlar to Amgen's Neupogen, U.S. senators want the FDA to lay down guidelines on naming these drugs.
MULTIMEDIA